Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting TYK2 can restore hair growth in alopecia areata.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Baricitinib was effective in treating alopecia areata in two major trials.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Baricitinib was effective in treating both early and late onset alopecia areata.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Baricitinib is effective and safe for treating severe alopecia areata.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

PPARα agonists may help treat alopecia areata by reducing inflammation.